Smithwise and Catapult have joined teams to become Archimedic! Read More.

Telehealth Platform for COPD Patients and their Clinicians

According to the American Lung Association, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in the U.S. 

20% of COPD hospital patients are readmitted after discharge within 30 days, with an average cost to hospitals of $12,000 per readmission ($1.4B annually).  

Basil Leaf Technologies is teaming up with Archimedic to develop and commercialize DxTER, a connected health monitoring platform to collect important monitoring data from a patient in the comfort of their home and share it with their care team.   



“It’s been great working with [Archimedic] because they’ve been able to get us focused and on track in a very logical trajectory. I was trying to go all directions at the same time and it was really not sustainable.”


Basil Harris, MD, PhD

Founder, Basil Leaf Technologies

Medtech Leaders Trust Archimedic